Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FEUL
Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ
FEUL
|
+$302M |
| 2 |
FFEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
|
+$273M |
| 3 |
Petrobras
PBR
|
+$272M |
| 4 |
BHP
BHP
|
+$266M |
| 5 |
Freeport-McMoran
FCX
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$460M |
| 2 |
FIEU
FI Enhanced Europe 50 ETN
FIEU
|
+$267M |
| 3 |
FLEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series B
FLEU
|
+$239M |
| 4 |
HDFC Bank
HDB
|
+$227M |
| 5 |
Comcast
CMCSA
|
+$227M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.36% |
| 2 | Technology | 15.02% |
| 3 | Healthcare | 11.86% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Consumer Staples | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
iShares Europe ETF
IEV
$1.67B
| $4.51M | 0.01% |
100,826
-7,230
| -7% | -$340K |
|
402
Worthington Enterprises
WOR
$2.77B
| $4.43M | 0.01% |
+171,188
| New | +$4.84M |
|
403
Myriad Genetics
MYGN
$270M
| $4.41M | 0.01% |
118,086
+4,797
| +4% | +$162K |
|
404
Clorox
CLX
$11.6B
| $4.39M | 0.01% |
32,473
+662
| +2% | +$81.7K |
|
405
Sarepta Therapeutics
SRPT
$1.57B
| $4.39M | 0.01% |
33,187
-6,044
| -15% | -$570K |
|
406
Medpace
MEDP
$16.1B
| $4.26M | 0.01% |
99,100
-29,663
| -23% | -$1.2M |
|
407
Korn Ferry
KFY
$4.18B
| $4.25M | 0.01% |
68,554
-16,051
| -19% | -$902K |
|
408
Hain Celestial
HAIN
$45M
| $4.24M | 0.01% |
142,265
-13,368
| -9% | -$383K |
|
409
Rexford Industrial Realty
REXR
$8.42B
| $4.14M | 0.01% |
131,905
-29,359
| -18% | -$898K |
|
410
Nike
NKE
$61.9B
| $4.1M | 0.01% |
51,471
+11,912
| +30% | +$839K |
|
411
Ironwood Pharmaceuticals
IRWD
$696M
| $4.04M | 0.01% |
252,221
-67,415
| -21% | -$998K |
|
412
Eagle Bancorp
EGBN
$846M
| $4.02M | 0.01% |
65,617
-18,372
| -22% | -$1.12M |
|
|
GWB
413
DELISTED
Great Western Bancorp, Inc.
GWB
| $4M | 0.01% |
95,175
-27,023
| -22% | -$1.14M |
|
|
CRZO
414
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $3.98M | 0.01% |
+142,916
| New | +$3.3M |
|
415
WPP
WPP
$4.36B
| $3.98M | 0.01% |
50,585
-3,432
| -6% | -$285K |
|
|
JNPR
416
DELISTED
Juniper Networks
JNPR
| $3.97M | 0.01% |
144,816
-11,894
| -8% | -$310K |
|
|
FARO
417
DELISTED
Faro Technologies
FARO
| $3.88M | 0.01% |
71,482
-10,605
| -13% | -$592K |
|
418
Bruker
BRKR
$9.57B
| $3.88M | 0.01% |
133,737
-14,263
| -10% | -$433K |
|
|
IPG
419
DELISTED
Interpublic Group of Companies
IPG
| $3.85M | 0.01% |
164,227
+312
| +0.2% | +$7.34K |
|
420
Affiliated Managers Group
AMG
$9.69B
| $3.8M | ﹤0.01% |
25,536
| – | – |
|
421
Stewart Information Services
STC
$2.06B
| $3.79M | ﹤0.01% |
88,085
-7,256
| -8% | -$311K |
|
422
Check Point Software Technologies
CHKP
$13B
| $3.78M | ﹤0.01% |
38,694
-1,184
| -3% | -$117K |
|
|
ADMS
423
DELISTED
Adamas Pharmaceuticals
ADMS
| $3.77M | ﹤0.01% |
146,129
+109,698
| +301% | +$3.04M |
|
424
Installed Building Products
IBP
$6.01B
| $3.76M | ﹤0.01% |
66,481
-14,567
| -18% | -$863K |
|
|
ICPT
425
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.74M | ﹤0.01% |
44,587
+4,835
| +12% | +$354K |
|
Similar funds
Ken Fisher's Q2 2018 Portfolio in Review
As of Q2 2018, Ken Fisher held 924 positions worth $77B, up 2.1% from $75.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher's Q2 2018 filing shows 95 new, 298 increased, 389 reduced and 62 closed positions. Its largest new stake was Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ: 3,218,864 shares worth $294M. The largest sale was Amazon, an estimated $460M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q2 2018 buy was Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ: 3,218,864 shares worth $294M.
- Ken Fisher added most to Barclays ETN+ FI Enhanced Europe 50 ETN Series C in Q2 2018, an estimated $273M increase.
- Ken Fisher's biggest Q2 2018 reduction was Amazon, cutting an estimated $460M.
- Ken Fisher fully exited Dr. Reddy's Laboratories in Q2 2018, selling an estimated $165M.
- Ken Fisher's ten largest holdings make up 26% of its $77B portfolio in Q2 2018.
- Ken Fisher opened 95 new positions and closed 62 in Q2 2018.
- Ken Fisher's portfolio value rose 2.1% quarter-over-quarter to $77B.
Based on Fisher Asset Management's 13F filing for Q2 2018, filed 9 Jul 2018.